Advanced in Light Chain Deposition Disease (LCDD)

Antoine L. Roux

Suresnes, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Light Chain Deposition Disease (LCDD)
Suresnes, FR 
OverviewLocationsClinical Research

Overview

Antoine Roux practices in Suresnes, France. Mr. Roux is rated as an Advanced expert by MediFind in the treatment of Light Chain Deposition Disease (LCDD). His top areas of expertise are Bronchiolitis Obliterans, Pneumocystis Jiroveci Pneumonia, Light Chain Deposition Disease (LCDD), Lung Transplant, and Heart Transplant.

His clinical research consists of co-authoring 149 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Light Chain Deposition Disease (LCDD).

Gender
Male

Locations

Suresnes, France
Other Locations
Clermont-ferrand, France
Saint-quentin-le-verger, France
Paris, 75015, France
Jouy-sur-morin, France
Versailles, France
Georges, France
France
Limoges, France
Nantes, France
Montigny-sur-loing, France
Boulogne-billancourt, 92100, France
Garches, France
Talence, France
114 Rue Edouard Vaillant, Villejuif, 94805, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Intérêt Diagnostique et Pronostique de la présence d'Anticorps spécifiques du Donneur Intra-greffon Dans le Rejet Humoral en Transplantation Pulmonaire
Intérêt Diagnostique et Pronostique de la présence d'Anticorps spécifiques du Donneur Intra-greffon Dans le Rejet Humoral en Transplantation Pulmonaire
Enrollment Status: Recruiting
Publish Date: February 14, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drugs: Alcoholic Povidone Iodine, Alcoholic Chlorhexidine
Study Phase: Phase 4
PREdiction of Chronic LUng Allograft Dysfunction
PREdiction of Chronic LUng Allograft Dysfunction
Enrollment Status: Active_not_recruiting
Publish Date: May 16, 2025
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
Preliminary Evaluation of the AIFib Software in Real Time as a Medical Decision Aid for the Detection of Atrial Fibrillation Driver
Preliminary Evaluation of the AIFib Software in Real Time as a Medical Decision Aid for the Detection of Atrial Fibrillation Driver
Enrollment Status: Completed
Publish Date: June 23, 2021
Intervention Type: Diagnostic test
View 4 Less Clinical Trials

149 Total Publications

Countrywide introduction of pulsed field ablation for the treatment of atrial fibrillation: Acute results from the FRANCE-PFA registry.
Countrywide introduction of pulsed field ablation for the treatment of atrial fibrillation: Acute results from the FRANCE-PFA registry.
Journal: Heart rhythm O2
Published: July 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roux's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile